Rosa P. Gomariz

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

Mario Delgado, Catalina Abad, Carmen Martı́nez et al. · Nature Medicine · 2001 · 380 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

Catalina Abad, Carmen Martínez, Marı́a G. Juarranz et al. · Gastroenterology · 2003 · 254 citations · Full text

Inflammation, Autoimmune Disease, Medicine +8

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.

Mario Delgado, Carmen Martínez, David Pozo et al. · PubMed · 1999 · 202 citations

Inflammation, Cytokine, Autoimmune Disease +15

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Enhance IL-10 Production by Murine Macrophages: In Vitro and In Vivo Studies

Mario Delgado, Ernesto J. Muñoz‐Elías, Rosa P. Gomariz et al. · The Journal of Immunology · 1999 · 197 citations · Full text

Immune Regulation, Immunology, Immunologic Mechanism +17

Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6

Mario Delgado, Carmen Martínez, David Pozo et al. · The Journal of Immunology · 1999 · 181 citations · Full text

Acute Lung Injury, Gastrointestinal Pharmacology, Immune Regulation +19